APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Drug Delivery Devices

Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.

Selected research

Market Analysis & Forecast

Global Drug Delivery Devices Market Analysis and Forecast 2026-2032

Report ID 173904480226 December 2025214 pages

Choose your research edition.

Industry ResearchDrug Delivery Devices Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Delivery Devices Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Delivery Devices Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Delivery Devices Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.

The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world's research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.

Report Includes

Read the full market overview

This report presents an overview of global market for Drug Delivery Devices, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Delivery Devices, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Delivery Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Delivery Devices revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Delivery Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Delivery Devices revenue, projected growth trends, production technology, application and end-user industry.

Drug Delivery Devices Segment by Company

Cipla

Baxter International

Nipro Corporation

Roche

Boehringer Ingelheim

Allergan

3M

BD

Catalent

Valeant Pharmaceuticals

Bayer AG

Chiesi

Phillips-Medisize

Johnson & Johnson

Shandong Weigao

Pfizer

B.Braun

Novartis AG

Zhengkang

Gerresheimer

COVIDIEN Medtronic

Schott forma vitrum

Alkermes

Skyepharma

Drug Delivery Devices Segment by Type

Injection Type

Mucosal Type

Implanted Type

Others Type

Drug Delivery Devices Segment by Application

Pharmaceutical Companies

Hospitals

Clinics

Other

Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Delivery Devices in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Delivery Devices company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Delivery Devices revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Delivery Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Type Major Player Table 3. Mucosal Type Major Player Table 4. Implanted Type Major Player Table 5. Others Type Major Player Table 6. Global Drug Delivery Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Companies Major Player Table 8. Hospitals Major Player Table 9. Clinics Major Player Table 10. Other Major Player Table 11. Drug Delivery Devices Industry Trends Table 12. Drug Delivery Devices Industry Drivers Table 13. Drug Delivery Devices Industry Opportunities and Challenges Table 14. Drug Delivery Devices Industry Restraints Table 15. Global Drug Delivery Devices Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Drug Delivery Devices Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Drug Delivery Devices Market Share by Region (2021-2026) Table 18. Global Drug Delivery Devices Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Drug Delivery Devices Market Share by Region (2027-2032) Table 20. Global Drug Delivery Devices Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Drug Delivery Devices Revenue Market Share by Players (2021-2026) Table 22. Global Drug Delivery Devices Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Drug Delivery Devices Key Players Headquarters & Area Served Table 24. Global Drug Delivery Devices Players, Product Type & Application Table 25. Global Drug Delivery Devices Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Drug Delivery Devices by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Drug Delivery Devices Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Drug Delivery Devices Revenue Market Share by Type (2021-2026) Table 32. Global Drug Delivery Devices Revenue Market Share by Type (2027-2032) Table 33. Global Drug Delivery Devices Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Drug Delivery Devices Revenue Market Share by Application (2021-2026) Table 37. Global Drug Delivery Devices Revenue Market Share by Application (2027-2032) Table 38. Cipla Company Information Table 39. Cipla Business Overview Table 40. Cipla Drug Delivery Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Cipla Drug Delivery Devices Product Portfolio Table 42. Cipla Recent Development Table 43. Baxter International Company Information Table 44. Baxter International Business Overview Table 45. Baxter International Drug Delivery Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Baxter International Drug Delivery Devices Product Portfolio Table 47. Baxter International Recent Development Table 48. Nipro Corporation Company Information Table 49. Nipro Corporation Business Overview Table 50. Nipro Corporation Drug Delivery Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Nipro Corporation Drug Delivery Devices Product Portfolio Table 52. Nipro Corporation Recent Development Table 53. Roche Company Information Table 54. Roche Business Overview Table 55. Roche Drug Delivery Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Roche Drug Delivery Devices Product Portfolio Table 57. Roche Recent Development Table 58. Boehringer Ingelheim Company Information Table 59. Boehringer Ingelheim Business Overview Table 60. Boehringer Ingelheim Drug Delivery Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Boehringer Ingelheim Drug Delivery Devices Product Portfolio Table 62. Boehringer Ingelheim Recent Development Table 63. Allergan Company Information Table 64. Allergan Business Overview Table 65. Allergan Drug Delivery Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Allergan Drug Delivery Devices Product Portfolio Table 67. Allergan Recent Development Table 68. 3M Company Information Table 69. 3M Business Overview Table 70. 3M Drug Delivery Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. 3M Drug Delivery Devices Product Portfolio Table 72. 3M Recent Development Table 73. BD Company Information Table 74. BD Business Overview Table 75. BD Drug Delivery Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. BD Drug Delivery Devices Product Portfolio Table 77. BD Recent Development Table 78. Catalent Company Information Table 79. Catalent Business Overview Table 80. Catalent Drug Delivery Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Catalent Drug Delivery Devices Product Portfolio Table 82. Catalent Recent Development Table 83. Valeant Pharmaceuticals Company Information Table 84. Valeant Pharmaceuticals Business Overview Table 85. Valeant Pharmaceuticals Drug Delivery Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio Table 87. Valeant Pharmaceuticals Recent Development Table 88. Bayer AG Company Information Table 89. Bayer AG Business Overview Table 90. Bayer AG Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Bayer AG Drug Delivery Devices Product Portfolio Table 92. Bayer AG Recent Development Table 93. Chiesi Company Information Table 94. Chiesi Business Overview Table 95. Chiesi Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Chiesi Drug Delivery Devices Product Portfolio Table 97. Chiesi Recent Development Table 98. Phillips-Medisize Company Information Table 99. Phillips-Medisize Business Overview Table 100. Phillips-Medisize Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Phillips-Medisize Drug Delivery Devices Product Portfolio Table 102. Phillips-Medisize Recent Development Table 103. Johnson & Johnson Company Information Table 104. Johnson & Johnson Business Overview Table 105. Johnson & Johnson Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Johnson & Johnson Drug Delivery Devices Product Portfolio Table 107. Johnson & Johnson Recent Development Table 108. Shandong Weigao Company Information Table 109. Shandong Weigao Business Overview Table 110. Shandong Weigao Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Shandong Weigao Drug Delivery Devices Product Portfolio Table 112. Shandong Weigao Recent Development Table 113. Pfizer Company Information Table 114. Pfizer Business Overview Table 115. Pfizer Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Pfizer Drug Delivery Devices Product Portfolio Table 117. Pfizer Recent Development Table 118. B.Braun Company Information Table 119. B.Braun Business Overview Table 120. B.Braun Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. B.Braun Drug Delivery Devices Product Portfolio Table 122. B.Braun Recent Development Table 123. Novartis AG Company Information Table 124. Novartis AG Business Overview Table 125. Novartis AG Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Novartis AG Drug Delivery Devices Product Portfolio Table 127. Novartis AG Recent Development Table 128. Zhengkang Company Information Table 129. Zhengkang Business Overview Table 130. Zhengkang Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. Zhengkang Drug Delivery Devices Product Portfolio Table 132. Zhengkang Recent Development Table 133. Gerresheimer Company Information Table 134. Gerresheimer Business Overview Table 135. Gerresheimer Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 136. Gerresheimer Drug Delivery Devices Product Portfolio Table 137. Gerresheimer Recent Development Table 138. COVIDIEN Medtronic Company Information Table 139. COVIDIEN Medtronic Business Overview Table 140. COVIDIEN Medtronic Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 141. COVIDIEN Medtronic Drug Delivery Devices Product Portfolio Table 142. COVIDIEN Medtronic Recent Development Table 143. Schott forma vitrum Company Information Table 144. Schott forma vitrum Business Overview Table 145. Schott forma vitrum Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 146. Schott forma vitrum Drug Delivery Devices Product Portfolio Table 147. Schott forma vitrum Recent Development Table 148. Alkermes Company Information Table 149. Alkermes Business Overview Table 150. Alkermes Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 151. Alkermes Drug Delivery Devices Product Portfolio Table 152. Alkermes Recent Development Table 153. Skyepharma Company Information Table 154. Skyepharma Business Overview Table 155. Skyepharma Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 156. Skyepharma Drug Delivery Devices Product Portfolio Table 157. Skyepharma Recent Development Table 158. North America Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 159. North America Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 160. North America Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 161. North America Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 162. North America Drug Delivery Devices Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. North America Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 164. North America Drug Delivery Devices Revenue by Country (US$ Million) & (2027-2032) Table 165. Europe Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 166. Europe Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 167. Europe Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe Drug Delivery Devices Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Europe Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 171. Europe Drug Delivery Devices Revenue by Country (US$ Million) & (2027-2032) Table 172. China Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 173. China Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 174. China Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 175. China Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 177. Asia Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 178. Asia Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Drug Delivery Devices Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Drug Delivery Devices Revenue by Region (US$ Million) & (2021-2026) Table 182. Asia Drug Delivery Devices Revenue by Region (US$ Million) & (2027-2032) Table 183. SAMEA Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Drug Delivery Devices Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. SAMEA Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 189. SAMEA Drug Delivery Devices Revenue by Country (US$ Million) & (2027-2032) Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Drug Delivery Devices Image Figure 2. Global Drug Delivery Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Delivery Devices Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Type Image Figure 5. Mucosal Type Image Figure 6. Implanted Type Image Figure 7. Others Type Image Figure 8. Global Drug Delivery Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Drug Delivery Devices Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Companies Image Figure 11. Hospitals Image Figure 12. Clinics Image Figure 13. Other Image Figure 14. Global Drug Delivery Devices Market Size (US$ Million) & (2021-2032) Figure 15. Global Drug Delivery Devices Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Drug Delivery Devices Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Drug Delivery Devices Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Drug Delivery Devices Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Drug Delivery Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Drug Delivery Devices Revenue Market Share by Type (2021-2032) Figure 22. Global Drug Delivery Devices Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Drug Delivery Devices Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Drug Delivery Devices Revenue Market Share by Application (2021-2032) Figure 25. North America Drug Delivery Devices Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Drug Delivery Devices Revenue Share by Type (2021-2032) Figure 27. North America Drug Delivery Devices Revenue Share by Application (2021-2032) Figure 28. North America Drug Delivery Devices Revenue Share by Country (2021-2032) Figure 29. United States Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Drug Delivery Devices Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Drug Delivery Devices Revenue Share by Type (2021-2032) Figure 34. Europe Drug Delivery Devices Revenue Share by Application (2021-2032) Figure 35. Europe Drug Delivery Devices Revenue Share by Country (2021-2032) Figure 36. Germany Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Drug Delivery Devices Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Drug Delivery Devices Revenue Share by Type (2021-2032) Figure 46. China Drug Delivery Devices Revenue Share by Application (2021-2032) Figure 47. Asia Drug Delivery Devices Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Drug Delivery Devices Revenue Share by Type (2021-2032) Figure 49. Asia Drug Delivery Devices Revenue Share by Application (2021-2032) Figure 50. Asia Drug Delivery Devices Revenue Share by Region (2021-2032) Figure 51. Japan Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Drug Delivery Devices Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Drug Delivery Devices Revenue Share by Type (2021-2032) Figure 59. SAMEA Drug Delivery Devices Revenue Share by Application (2021-2032) Figure 60. SAMEA Drug Delivery Devices Revenue Share by Country (2021-2032) Figure 61. Brazil Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Drug Delivery Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Type
  • Mucosal Type
  • Implanted Type
  • Others Type
Applications
  • Pharmaceutical Companies
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Cipla
  • Baxter International
  • Nipro Corporation
  • Roche
  • Boehringer Ingelheim
  • Allergan
  • 3M
  • BD
  • Catalent
  • Valeant Pharmaceuticals
  • Bayer AG
  • Chiesi
  • Phillips-Medisize
  • Johnson & Johnson
  • Shandong Weigao
  • Pfizer
  • B.Braun
  • Novartis AG
  • Zhengkang
  • Gerresheimer
  • COVIDIEN Medtronic
  • Schott forma vitrum
  • Alkermes
  • Skyepharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Delivery Devices Market by Type
  3. 1.2.1 Global Drug Delivery Devices Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection Type
  5. 1.2.3 Mucosal Type
  6. 1.2.4 Implanted Type
  7. 1.2.5 Others Type
  8. 1.3 Drug Delivery Devices Market by Application
  9. 1.3.1 Global Drug Delivery Devices Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Companies
  11. 1.3.3 Hospitals
  12. 1.3.4 Clinics
  13. 1.3.5 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Drug Delivery Devices Market Dynamics
  1. 2.1 Drug Delivery Devices Industry Trends
  2. 2.2 Drug Delivery Devices Industry Drivers
  3. 2.3 Drug Delivery Devices Industry Opportunities and Challenges
  4. 2.4 Drug Delivery Devices Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Delivery Devices Market Perspective (2021-2032)
  2. 3.2 Global Drug Delivery Devices Growth Trends by Region
  3. 3.2.1 Global Drug Delivery Devices Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Delivery Devices Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Delivery Devices Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Delivery Devices Revenue by Players
  2. 4.1.1 Global Drug Delivery Devices Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Delivery Devices Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Delivery Devices Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Delivery Devices Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Delivery Devices Key Players Headquarters & Area Served
  7. 4.4 Global Drug Delivery Devices Players, Product Type & Application
  8. 4.5 Global Drug Delivery Devices Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Delivery Devices Market CR5 and HHI
  11. 4.6.3 2025 Drug Delivery Devices Tier 1, Tier 2, and Tier 3
5 Drug Delivery Devices Market Size by Type
  1. 5.1 Global Drug Delivery Devices Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Delivery Devices Revenue by Type (2021-2032)
  3. 5.3 Global Drug Delivery Devices Revenue Market Share by Type (2021-2032)
6 Drug Delivery Devices Market Size by Application
  1. 6.1 Global Drug Delivery Devices Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Delivery Devices Revenue by Application (2021-2032)
  3. 6.3 Global Drug Delivery Devices Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Cipla
  2. 7.1.1 Cipla Company Information
  3. 7.1.2 Cipla Business Overview
  4. 7.1.3 Cipla Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Cipla Drug Delivery Devices Product Portfolio
  6. 7.1.5 Cipla Recent Developments
  7. 7.2 Baxter International
  8. 7.2.1 Baxter International Company Information
  9. 7.2.2 Baxter International Business Overview
  10. 7.2.3 Baxter International Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Baxter International Drug Delivery Devices Product Portfolio
  12. 7.2.5 Baxter International Recent Developments
  13. 7.3 Nipro Corporation
  14. 7.3.1 Nipro Corporation Company Information
  15. 7.3.2 Nipro Corporation Business Overview
  16. 7.3.3 Nipro Corporation Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Nipro Corporation Drug Delivery Devices Product Portfolio
  18. 7.3.5 Nipro Corporation Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Roche Drug Delivery Devices Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Boehringer Ingelheim
  26. 7.5.1 Boehringer Ingelheim Company Information
  27. 7.5.2 Boehringer Ingelheim Business Overview
  28. 7.5.3 Boehringer Ingelheim Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Boehringer Ingelheim Drug Delivery Devices Product Portfolio
  30. 7.5.5 Boehringer Ingelheim Recent Developments
  31. 7.6 Allergan
  32. 7.6.1 Allergan Company Information
  33. 7.6.2 Allergan Business Overview
  34. 7.6.3 Allergan Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Allergan Drug Delivery Devices Product Portfolio
  36. 7.6.5 Allergan Recent Developments
  37. 7.7 3M
  38. 7.7.1 3M Company Information
  39. 7.7.2 3M Business Overview
  40. 7.7.3 3M Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  41. 7.7.4 3M Drug Delivery Devices Product Portfolio
  42. 7.7.5 3M Recent Developments
  43. 7.8 BD
  44. 7.8.1 BD Company Information
  45. 7.8.2 BD Business Overview
  46. 7.8.3 BD Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BD Drug Delivery Devices Product Portfolio
  48. 7.8.5 BD Recent Developments
  49. 7.9 Catalent
  50. 7.9.1 Catalent Company Information
  51. 7.9.2 Catalent Business Overview
  52. 7.9.3 Catalent Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Catalent Drug Delivery Devices Product Portfolio
  54. 7.9.5 Catalent Recent Developments
  55. 7.10 Valeant Pharmaceuticals
  56. 7.10.1 Valeant Pharmaceuticals Company Information
  57. 7.10.2 Valeant Pharmaceuticals Business Overview
  58. 7.10.3 Valeant Pharmaceuticals Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio
  60. 7.10.5 Valeant Pharmaceuticals Recent Developments
  61. 7.11 Bayer AG
  62. 7.11.1 Bayer AG Company Information
  63. 7.11.2 Bayer AG Business Overview
  64. 7.11.3 Bayer AG Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Bayer AG Drug Delivery Devices Product Portfolio
  66. 7.11.5 Bayer AG Recent Developments
  67. 7.12 Chiesi
  68. 7.12.1 Chiesi Company Information
  69. 7.12.2 Chiesi Business Overview
  70. 7.12.3 Chiesi Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Chiesi Drug Delivery Devices Product Portfolio
  72. 7.12.5 Chiesi Recent Developments
  73. 7.13 Phillips-Medisize
  74. 7.13.1 Phillips-Medisize Company Information
  75. 7.13.2 Phillips-Medisize Business Overview
  76. 7.13.3 Phillips-Medisize Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Phillips-Medisize Drug Delivery Devices Product Portfolio
  78. 7.13.5 Phillips-Medisize Recent Developments
  79. 7.14 Johnson & Johnson
  80. 7.14.1 Johnson & Johnson Company Information
  81. 7.14.2 Johnson & Johnson Business Overview
  82. 7.14.3 Johnson & Johnson Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Johnson & Johnson Drug Delivery Devices Product Portfolio
  84. 7.14.5 Johnson & Johnson Recent Developments
  85. 7.15 Shandong Weigao
  86. 7.15.1 Shandong Weigao Company Information
  87. 7.15.2 Shandong Weigao Business Overview
  88. 7.15.3 Shandong Weigao Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Shandong Weigao Drug Delivery Devices Product Portfolio
  90. 7.15.5 Shandong Weigao Recent Developments
  91. 7.16 Pfizer
  92. 7.16.1 Pfizer Company Information
  93. 7.16.2 Pfizer Business Overview
  94. 7.16.3 Pfizer Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Pfizer Drug Delivery Devices Product Portfolio
  96. 7.16.5 Pfizer Recent Developments
  97. 7.17 B.Braun
  98. 7.17.1 B.Braun Company Information
  99. 7.17.2 B.Braun Business Overview
  100. 7.17.3 B.Braun Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  101. 7.17.4 B.Braun Drug Delivery Devices Product Portfolio
  102. 7.17.5 B.Braun Recent Developments
  103. 7.18 Novartis AG
  104. 7.18.1 Novartis AG Company Information
  105. 7.18.2 Novartis AG Business Overview
  106. 7.18.3 Novartis AG Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Novartis AG Drug Delivery Devices Product Portfolio
  108. 7.18.5 Novartis AG Recent Developments
  109. 7.19 Zhengkang
  110. 7.19.1 Zhengkang Company Information
  111. 7.19.2 Zhengkang Business Overview
  112. 7.19.3 Zhengkang Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Zhengkang Drug Delivery Devices Product Portfolio
  114. 7.19.5 Zhengkang Recent Developments
  115. 7.20 Gerresheimer
  116. 7.20.1 Gerresheimer Company Information
  117. 7.20.2 Gerresheimer Business Overview
  118. 7.20.3 Gerresheimer Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Gerresheimer Drug Delivery Devices Product Portfolio
  120. 7.20.5 Gerresheimer Recent Developments
  121. 7.21 COVIDIEN Medtronic
  122. 7.21.1 COVIDIEN Medtronic Company Information
  123. 7.21.2 COVIDIEN Medtronic Business Overview
  124. 7.21.3 COVIDIEN Medtronic Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  125. 7.21.4 COVIDIEN Medtronic Drug Delivery Devices Product Portfolio
  126. 7.21.5 COVIDIEN Medtronic Recent Developments
  127. 7.22 Schott forma vitrum
  128. 7.22.1 Schott forma vitrum Company Information
  129. 7.22.2 Schott forma vitrum Business Overview
  130. 7.22.3 Schott forma vitrum Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Schott forma vitrum Drug Delivery Devices Product Portfolio
  132. 7.22.5 Schott forma vitrum Recent Developments
  133. 7.23 Alkermes
  134. 7.23.1 Alkermes Company Information
  135. 7.23.2 Alkermes Business Overview
  136. 7.23.3 Alkermes Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Alkermes Drug Delivery Devices Product Portfolio
  138. 7.23.5 Alkermes Recent Developments
  139. 7.24 Skyepharma
  140. 7.24.1 Skyepharma Company Information
  141. 7.24.2 Skyepharma Business Overview
  142. 7.24.3 Skyepharma Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Skyepharma Drug Delivery Devices Product Portfolio
  144. 7.24.5 Skyepharma Recent Developments
8 North America
  1. 8.1 North America Drug Delivery Devices Revenue (2021-2032)
  2. 8.2 North America Drug Delivery Devices Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Delivery Devices Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Delivery Devices Revenue by Type (2027-2032)
  5. 8.3 North America Drug Delivery Devices Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Delivery Devices Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Delivery Devices Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Delivery Devices Revenue by Application (2027-2032)
  9. 8.5 North America Drug Delivery Devices Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Delivery Devices Revenue by Country
  11. 8.6.1 North America Drug Delivery Devices Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Delivery Devices Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Delivery Devices Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug Delivery Devices Revenue (2021-2032)
  2. 9.2 Europe Drug Delivery Devices Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Delivery Devices Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Delivery Devices Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Delivery Devices Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Delivery Devices Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Delivery Devices Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Delivery Devices Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Delivery Devices Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Delivery Devices Revenue by Country
  11. 9.6.1 Europe Drug Delivery Devices Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Delivery Devices Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Delivery Devices Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug Delivery Devices Revenue (2021-2032)
  2. 10.2 China Drug Delivery Devices Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Delivery Devices Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Delivery Devices Revenue by Type (2027-2032)
  5. 10.3 China Drug Delivery Devices Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Delivery Devices Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Delivery Devices Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Delivery Devices Revenue by Application (2027-2032)
  9. 10.5 China Drug Delivery Devices Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Delivery Devices Revenue (2021-2032)
  2. 11.2 Asia Drug Delivery Devices Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Delivery Devices Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Delivery Devices Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Delivery Devices Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Delivery Devices Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Delivery Devices Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Delivery Devices Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Delivery Devices Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Delivery Devices Revenue by Country
  11. 11.6.1 Asia Drug Delivery Devices Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Delivery Devices Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Delivery Devices Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Delivery Devices Revenue (2021-2032)
  2. 12.2 SAMEA Drug Delivery Devices Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Delivery Devices Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Delivery Devices Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Delivery Devices Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Delivery Devices Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Delivery Devices Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Delivery Devices Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Delivery Devices Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Delivery Devices Revenue by Country
  11. 12.6.1 SAMEA Drug Delivery Devices Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Delivery Devices Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Delivery Devices Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst